Evaluation of the Effectiveness of Health Literacy Education Given to Women by Teach-Back Method
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorIstanbul University - Cerrahpasa
About this trial
This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. The research was designed as a randomized controlled study. In addition, this study aims to answer the question of whether health literacy education delivered using the teach-back method is effective in improving women's health literacy levels. Within the scope of the study, participants in the experimental group will receive health literacy education using the teach-back technique, while the control group will receive standard care. Data will be collected using a questionnaire method.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Women aged between 18 and 65 years
Those with a General Health Questionnaire-12 score below 4
Disqualifiers
Illiterate women
Male individuals
Those with communication difficulties
Healthcare professionals (physicians, midwives, nurses, etc.)
Trial design
Design model
Parallel
Treatments tested in this trial
teach-back
Other interventionThe experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week. The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.
Control Group
Other interventionThe control group will receive standard care
Treatment groups
74 Participants
are divided into 2 treatment groupsGroup A: Teach-backExperimental treatment 1 intervention
Group B: Control GroupOther 1 intervention
Trial outcomes
Primary outcomes
1
Health literacy
The Turkey Health Literacy Scale-32 will be used to measure health literacy levels. It is a scale consisting of 32 questions. The total score takes values between 0 and 50. 0 indicates the lowest health literacy level, and 50 indicates the highest health literacy level. According to the scoring system below, health literacy is defined as follows: a score of 0-25 indicates inadequate health literacy; a score of \>25-33 indicates problematic-limited health literacy; a score of \>33-42 indicates adequate health literacy; and a score of \>42-50 indicates excellent health literacy.
Time frame
Measurements will be taken at baseline, immediately after the training (week 6), and one month after the training (week 10).2
The General Self-Efficacy Scale
The General Self-Efficacy Scale will be used to measure the participants' self-efficacy levels. The scale is a 5-point Likert-type instrument consisting of three subdimensions and 17 items. The subdimensions are Initiation (9 items), Persistence (5 items), and Maintenance Effort-Determination (3 items). The total scale score ranges from 17 to 85, with higher total scores indicating a higher level of self-efficacy belief.
Time frame
Measurements will be taken at baseline, immediately after the training (week 6), and one month after the training (week 10).Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov